Psilera Unveils Novel, Non-Hallucinogenic Psilocybin Derivative PSIL-006 As Lead Clinical Candidate
/PRNewswire/ -- Psilera, a biopharmaceutical company developing next-generation mental health treatments for take home use, announces the selection of their...